Form 4 for DNA Ginkgo Bioworks Holdings, Inc.

Accepted 2022-06-13 00:00:00 ET · period of report 2022-06-10 · accession 0000899243-22-022291 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-06-13	2022-06-10	DNA	DEKKERS MARIJN E	Dir	A - Grant	$0.00	+70.9K	2.19M	+3%	$0
D	2022-06-13	2022-06-10	DNA	DEKKERS MARIJN E	Dir	A - Grant	$0.00	+108.5K	108.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2022-06-10	A	A	70,921	$0.00	2,192,587	D	—	—	(F1) The vesting date of the restricted stock units and stock options, and in the case of the stock options, the exercise date, will be the earlier of either June 10, 2023 or the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
2	Derivative	Stock Option	2022-06-10	A	A	108,516	$0.00	108,516	D	$2.82 · — to 2032-06-10	108,516 Class A Common Stock	(F3) In accordance with the Non-Employee Director Compensation Policy of the Issuer, the Black-Scholes value of the option award as of the grant date is $200,000. (F1) The vesting date of the restricted stock units and stock options, and in the case of the stock options, the exercise date, will be the earlier of either June 10, 2023 or the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.